HSV-1 gG Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of HSV-1 gG monoclonal antibodies for research focused on understanding glycoprotein G in herpes simplex virus type 1. HSV-1 gG monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein G (gG) serves as a critical component of the HSV-1 envelope, playing a significant role in viral entry and immune evasion. HSV-1 gG facilitates virus spread and establishes latency, making it a key target for therapeutic interventions and vaccine development. Understanding HSV-1 gG function remains essential for advancing knowledge of herpesvirus biology and developing effective treatments. Researchers worldwide rely on HSV-1 gG monoclonal antibodies to explore viral mechanisms and pathways. Current investigations using HSV-1 gG monoclonal antibodies continue to reveal new insights about viral infection processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of herpes simplex virus type 1 and support the development of innovative therapeutic strategies.